Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00189176
What this trial is testing

Safety Study of Tetrathiomolybdate in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
University of Michigan 23
Not applicableNo Longer AvailableNCT04739150
What this trial is testing

An Expanded Access Program in Belgium to Provide Nintedanib to People With Lung Diseases Called Non-IPF ILDs Who Have no Alternative Treatment Options

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim
Not applicableUnknownNCT00168285
What this trial is testing

Pulmonary Rehabilitation in Interstitial Lung Disease

Who this might be right for
Interstitial Lung Disease
The Alfred 56
Very early researchNot Yet RecruitingNCT07359963
What this trial is testing

Treatment of Idiopathic Pulmonary Fibrosis (IPF) by REGEND007 Cell Therapy

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Regend Therapeutics 12
Early research (Phase 1)Study completedNCT06160440
What this trial is testing

The Safety, Tolerability, and Pharmacokinetic Study of SC1011 in Healthy Subjects.

Who this might be right for
Diopathic Pulmonary FibrosisPulmonary Fibrosis
Guangzhou JOYO Pharma Co., Ltd 55
Testing effectiveness (Phase 2)Study completedNCT02707640
What this trial is testing

Assess the Safety and Tolerability of N-Acetylcysteine When Administered With Pirfenidone to Participants With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Hoffmann-La Roche 123
Not applicableActive Not RecruitingNCT07560189
What this trial is testing

IPF Longitudinal Natural History Study

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Assiut University 1,423
Testing effectiveness (Phase 2)Ended earlyNCT01203943
What this trial is testing

Characterize the Safety, PK and Biological Activity of CC-930 in Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary FibrosisPulmonary FibrosisFibrosis+2 more
Celgene 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT05060822
What this trial is testing

Phase ll Study of HEC585 in Patients With IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis
Sunshine Lake Pharma Co., Ltd. 270
Testing effectiveness (Phase 2)Ended earlyNCT05032066
What this trial is testing

Trial to Evaluate the Efficacy, Safety and Tolerability of HZN-825 in Subjects With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Amgen 153
Early research (Phase 1)Not Yet RecruitingNCT07682337
What this trial is testing

Study of Single and Multiple Oral Doses of SCB0020160 in Healthy Adult Male Subjects

Who this might be right for
Solid TumorObesityIdiopathic Pulmonary Fibrosis
SCBIO Inc. 74
Not applicableStudy completedNCT02445157
What this trial is testing

Reliability of the 4 Metre Gait Speed in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Royal Brompton & Harefield NHS Foundation Trust 46
Testing effectiveness (Phase 2)Study completedNCT02257177
What this trial is testing

RCT (Randomized Control Trial) of TD139 vs Placebo in HV's (Human Volunteers) and IPF Patients

Who this might be right for
Idiopathic Pulmonary Fibrosis
Galecto Biotech AB 60
Not applicableEnded earlyNCT00005295
What this trial is testing

Idiopathic Pulmonary Fibrosis: a Case-control Study

Who this might be right for
Lung DiseasesPulmonary FibrosisLung Diseases, Interstitial
University of New Mexico
Large-scale testing (Phase 3)Ended earlyNCT00768300
What this trial is testing

(ARTEMIS-IPF) Randomized, Placebo-Controlled Study to Evaluate Safety and Effectiveness of Ambrisentan in IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis
Gilead Sciences 494
Not applicableUnknownNCT04693975
What this trial is testing

Social Distancing During the COVID-19 Pandemic and People Living With Chronic Respiratory Diseases

Who this might be right for
Chronic Obstructive Pulmonary DiseaseIdiopathic Pulmonary FibrosisAsthma Chronic
Universidade Estadual de Londrina 94
Not applicableUnknownNCT02176707
What this trial is testing

Modelling of Quality Life, Clinical and Physiological Measures in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisDyspnoeaAnxiety+1 more
University of East Anglia 250
Early research (Phase 1)UnknownNCT05912049
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetic Properties and Immunogenicity of 9MW3811 in Healthy Subjects

Who this might be right for
Idiopathic Pulmonary Fibrosis
Mabwell (Shanghai) Bioscience Co., Ltd. 24
Large-scale testing (Phase 3)Study completedNCT00517933
What this trial is testing

Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis

Who this might be right for
Pulmonary FibrosisHypertension, Pulmonary
Duke University 180
Early research (Phase 1)Ended earlyNCT03069989
What this trial is testing

Single Doses of GSK3008348 in Idiopathic Pulmonary Fibrosis (IPF) Participants Using Positron Emission Tomography (PET) Imaging

Who this might be right for
Idiopathic Pulmonary Fibrosis
GlaxoSmithKline 8
Next Page